On the recordDecember 12, 2017
I agree with just about everything that my colleague just finished saying and I hope... we are kind of reaching the end of our tether.
Source
congress.govEditor's note · Context
Sarbanes emphasizes bipartisan frustration with drug pricing transparency.
Share & report
More from John Sarbanes
Feb 6, 2023
They are really unleashing more profit-making by the big oil companies, and doing that at the expense of the American people.
Apr 25, 2023
Maryland's total-cost-of-care model also allows our State to invest in other health system goals, like lowering the maternal mortality rate and the opioid overdose mortality rate.
Apr 25, 2023
If we have a better understanding of these factors, we can address them more effectively, which will, in turn, improve patient access and care overall.
Sep 28, 2022
What delays people in getting the care that they need is when we have these abortion bans forcing people out of their communities.
Other voices in this conversation
